| 4I77: reference: Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab., Ultsch M, Bevers J, Nakamura G, Vandlen R, Kelley RF, Wu LC, Eigenbrot C, J Mol Biol. 2013 Jan 25. pii: S0022-2836(13)00040-5. doi:, 10.1016/j.jmb.2013.01.024. PMID: 23357170 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).